Article Versions Notes

Nizamuddin I, Demir T, Dobinda K, Chen R, Kocherginsky M, Doukas P, Katam N, Moloney C, Mahalingam D. Clinical and Molecular Differences Suggest Different Responses to Immune Checkpoint Inhibitors in Microsatellite-Stable Solid Tumors with High Tumor Mutational Burden. Cancers. 2025; 17(16):2673. https://doi.org/10.3390/cancers17162673

Nizamuddin, Imran, Tarik Demir, Katrina Dobinda, Ruohui Chen, Masha Kocherginsky, Peter Doukas, Neelima Katam, Carolyn Moloney, and Devalingam Mahalingam. 2025. "Clinical and Molecular Differences Suggest Different Responses to Immune Checkpoint Inhibitors in Microsatellite-Stable Solid Tumors with High Tumor Mutational Burden" Cancers 17, no. 16: 2673. https://doi.org/10.3390/cancers17162673

Nizamuddin, I., Demir, T., Dobinda, K., Chen, R., Kocherginsky, M., Doukas, P., Katam, N., Moloney, C., & Mahalingam, D. (2025). Clinical and Molecular Differences Suggest Different Responses to Immune Checkpoint Inhibitors in Microsatellite-Stable Solid Tumors with High Tumor Mutational Burden. Cancers, 17(16), 2673. https://doi.org/10.3390/cancers17162673